AMANTA vs FISCHER: Stock Comparison

AMANTA vs FISCHER MEDICAL VENTURE LUpdated 16 Jun 26, 4:08 PM ISTNSE & company filings

FISCHER MEDICAL VENTURE L is the larger company by market capitalisation. AMANTA shows a lower P/E, while FISCHER MEDICAL VENTURE L shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AMANTA leads 3; FISCHER leads 9 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AMANTAFISCHER

Valuation lens

What price are you paying?

Market CapContext only
₹749 Cr
₹2,194 Cr
P/E RatioAMANTA has the lower reading
53.58x
72.17x
P/B RatioAMANTA has the lower reading
3.57x
5.66x
EPSAMANTA has the higher reading
₹0.85
₹0.45
Book ValueContext only
₹56.71
₹5.96
Dividend YieldFISCHER has the higher reading
0%
0.15%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
FISCHER is the larger company
₹2,194 Cr vs ₹749 Cr
P/E Ratio
AMANTA has a lower P/E
53.58x vs 72.17x
P/B Ratio
AMANTA has a lower P/B
3.57x vs 5.66x
EPS
AMANTA has higher earnings per share
₹0.85 vs ₹0.45
Dividend Yield
FISCHER has a higher dividend yield
0.15% vs 0%
Revenue Growth (TTM YoY)
FISCHER has faster revenue growth
98.7% vs 6.8%
EPS Growth (TTM YoY)
FISCHER has faster EPS growth
0% vs -23.4%
Qtr Sales Growth
FISCHER has stronger quarterly sales growth
11,250.98% vs -76.08%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAMANTAFISCHER
SectorHealthcareHealthcare
IndustryPharmaceuticalsMedical Equipment & Supplies

Price

MetricAMANTAFISCHER
Live Price₹150.27₹33.74
Day Change-4.37%0.72%
Volume3.82 L1.53 L
52-Week High₹164₹124.7
52-Week Low₹92₹31.05
Distance from 52W High-8.37%-72.94%

Valuation

MetricAMANTAFISCHER
Market Cap₹749 Cr₹2,194 Cr
P/E Ratio53.58x72.17x
P/B Ratio3.57x5.66x
EPS₹0.85₹0.45
Book Value₹56.71₹5.96
Dividend Yield0%0.15%

Growth

MetricAMANTAFISCHER
Revenue Growth (TTM YoY)6.8%98.7%
EPS Growth (TTM YoY)-23.4%0%
Qtr Sales Growth-76.08%11,250.98%
Qtr Profit Growth-77.74%208.2%

Profitability & Leverage

MetricAMANTAFISCHER
ROE6.75%8.05%
ROCE7.89%7.89%
Net Margin5.17%6.79%
Operating Margin14.55%16.99%
Debt to Equity1.06x0.19x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAMANTAFISCHER
Promoter Holding26.87% 0.06 pp12.31% 0.85 pp
FII Holding0.43% 0.42 pp5.57% 0.09 pp
DII Holding12.92% 0.04 pp1.26% 0.09 pp
Public Holding22.85% 0.29 pp30.09% 0.93 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMANTA and FISCHER MEDICAL VENTURE L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.